Results 51 to 60 of about 4,208 (295)
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka +9 more
wiley +1 more source
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski +12 more
wiley +1 more source
De rentecurve voor de waardering van langetermijngaranties op de Solvency II-balans [PDF]
Vanaf 2016 geldt een nieuw toezichtskader voor verzekeraars opererend binnen de Europese Unie, genaamd Solvency II. In dit toezichtskader staan marktwaarden en risico’s centraal, waardoor meer kapitaal aangehouden moet worden voor risicovolle producten ...
Paul van Ammelrooij
doaj +3 more sources
CRISPRI‐mediated gene silencing and phenotypic exploration in nontuberculous mycobacteria. In this Research Protocol, we describe approaches to control, monitor, and quantitatively assess CRISPRI‐mediated gene silencing in M. smegmatis and M. abscessus model organisms.
Vanessa Point +7 more
wiley +1 more source
Assessment of the Stability of Insurance Companies: The Case of Baltic Non-Life Insurance Market
The study gives an overview of the Baltic non-life insurance market. The purpose of the research is to summarise stability statistics on solvency ratios, risk profiles and capital surplus, which was contained in Solvency and Financial Condition reports ...
Zariņa Ilze +2 more
doaj +1 more source
Ryzyko zakładów ubezpieczeń w świetle nowych wymogów kapitałowych Solvency II
The aim of this work is to conduct the key aspects of a heated debate about effects and issues connected with implementing a new solution of risk management in insurance companies included in Solvency II.
Teresa Czerwińska
doaj +1 more source
Enzymes of the 2‐hydroxyacyl‐CoA lyase group catalyze the condensation of formyl‐CoA with aldehydes or ketones. Thus, by structural adaptation of active sites, practically any pharmaceutically and industrially important 2‐hydroxyacid could be biotechnologically synthesized. Combining crystal structure analysis, active site mutations and kinetic assays,
Michael Zahn +4 more
wiley +1 more source
Time‐resolved X‐ray solution scattering captures how proteins change shape in real time under near‐native conditions. This article presents a practical workflow for light‐triggered TR‐XSS experiments, from data collection to structural refinement. Using a calcium‐transporting membrane protein as an example, the approach can be broadly applied to study ...
Fatemeh Sabzian‐Molaei +3 more
wiley +1 more source

